| 000 | 00927 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250513035053.0 | ||
| 264 | 0 | _c19950725 | |
| 008 | 199507s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199507203330313 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDisla, E | |
| 245 | 0 | 0 |
_aInterleukin-2 as therapy for HIV disease. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJul 1995 |
||
| 300 |
_a192; author reply 193 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 |
_aHIV Infections _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfasalazine _xtherapeutic use |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 333 _gno. 3 _gp. 192; author reply 193 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199507203330313 _zAvailable from publisher's website |
| 999 |
_c7646121 _d7646121 |
||